Advancing Safe Medications for Moms and Babies Act of 2026

Referred to the House Committee on Energy and Commerce.

2026-05-04

The legislation would require the Food and Drug Administration to improve how it evaluates and labels medications that pregnant women and nursing mothers take, ensuring that doctors and patients have better information about safety risks for both mother and baby. It would also establish new research programs to fill gaps in knowledge about which drugs are safe during pregnancy and breastfeeding, since many medications have never been properly tested in these situations. The changes would affect pregnant women, new mothers, their healthcare providers, and pharmaceutical companies that develop and market these drugs.